{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:38:00Z","timestamp":1794649080161,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jneuroim.2023.578083","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T13:46:27Z","timestamp":1680702387000},"page":"578083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Paediatric MOG-antibody disease presenting with intracranial hypertension and unilateral vision loss without radiological evidence of optic neuritis"],"prefix":"10.1016","volume":"378","author":[{"given":"Jack Jonathan","family":"Maran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2023.578083_bb0005","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032986","article-title":"Pediatric myelin oligodendrocyte glycoprotein antibody associated disease-asymmetric papilledema and elevated ICP are two of the chameleons: a case report","volume":"102","author":"Alqahtani","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jneuroim.2023.578083_bb0010","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/02713683.2019.1567792","article-title":"Optical coherence tomography of the retinal ganglion cell complex in Leber\u2019s hereditary optic neuropathy and dominant optic atrophy","volume":"44","author":"Asanad","year":"2019","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2015.06.003","article-title":"Papilledema outcomes from the optical coherence tomography substudy of the idiopathic intracranial hypertension treatment trial","volume":"122","author":"Auinger","year":"2015","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ophtha.2004.06.034","article-title":"Retinal nerve fiber layer evaluation by optical coherence tomography in Leber\u2019s hereditary optic neuropathy","volume":"112","author":"Barboni","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jneuroim.2023.578083_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejpn.2020.10.002","article-title":"E.U. paediatric MOG consortium consensus: part 2 \u2013 neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Baumann","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The optic neuritis study group","volume":"326","author":"Beck","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejpn.2020.10.006","article-title":"E.U. paediatric MOG consortium consensus: part 1 \u2013 classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0040","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as intracranial hypertension","volume":"9","author":"Chaudhuri","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2023.578083_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/WCO.0000000000000766","article-title":"Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis","volume":"33","author":"Chen","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0050","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1167\/iovs.15-16450","article-title":"Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension","volume":"56","author":"Chen","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0055","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41433-020-01334-8","article-title":"Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment","volume":"35","author":"Gospe","year":"2021","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.jneuroim.2023.578083_bb0060","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/1352458517726593","article-title":"Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody","volume":"24","author":"Hacohen","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0065","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1007\/s00415-022-11130-x","article-title":"Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination","volume":"269","author":"Jeantin","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0070","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0075","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00415-018-8956-y","article-title":"Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation","volume":"265","author":"Lotan","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12883-021-02198-5","article-title":"The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder","volume":"21","author":"Maghbooli","year":"2021","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0085","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fneur.2019.00868","article-title":"Myelin oligodendrocyte glycoprotein (MOG) antibody diseases in children in central South China: clinical features, treatments, influencing factors, and outcomes","volume":"10","author":"Mao","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0090","series-title":"StatPearls","article-title":"Toxic and nutritional optic neuropathy","author":"Margolin","year":"2022"},{"key":"10.1016\/j.jneuroim.2023.578083_bb0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(15)00298-7","article-title":"Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions","volume":"15","author":"Markey","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/acn3.51291","article-title":"Obesity and the risk of multiple sclerosis. The role of leptin","volume":"8","author":"Marrodan","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/WCO.0000000000000636","article-title":"The role of optical coherence tomography in the evaluation of compressive optic neuropathies","volume":"32","author":"Micieli","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0110","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/1352458519845112","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","volume":"26","author":"de Mol","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.msard.2018.10.003","article-title":"Atypical anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations","volume":"27","author":"Narayan","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pediatrneurol.2015.01.002","article-title":"Elevated cerebrospinal fluid opening pressure in a pediatric demyelinating disease cohort","volume":"52","author":"Narula","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0125","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.eye.6701591","article-title":"Hereditary optic neuropathies","volume":"18","author":"Newman","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.jneuroim.2023.578083_bb0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-3-319-63260-5_8","article-title":"Multiple sclerosis: implications of obesity in Neuroinflammation","volume":"19","author":"Novo","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0135","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1167\/iovs.08-2528","article-title":"Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography","volume":"50","author":"Rebolleda","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0140","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.3390\/nu12092653","article-title":"Nutritional optic neuropathies: state of the art and emerging evidences","volume":"12","author":"Roda","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jneuroim.2023.578083_bb0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.22336\/rjo.2021.37","article-title":"Incidental idiopathic intracranial hypertension","volume":"65","author":"Sargues","year":"2021","journal-title":"Rom. J. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0150","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archopht.124.8.1111","article-title":"Detection and quantification of retinal nerve Fiber layer thickness in optic disc edema using stratus OCT","volume":"124","author":"Savini","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0155","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/FOC-07\/11\/E5","article-title":"Mechanisms of visual loss in papilledema","volume":"23","author":"Schirmer","year":"2007","journal-title":"Neurosurg. Focus FOC"},{"key":"10.1016\/j.jneuroim.2023.578083_bb0160","article-title":"Obesity and multiple sclerosis-a multifaceted association","volume":"102689","author":"Schreiner","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0165","doi-asserted-by":"crossref","first-page":"21312","DOI":"10.1038\/s41598-022-21592-8","article-title":"Obesity is associated with myelin oligodendrocyte glycoprotein antibody associated disease in acute optic neuritis","volume":"12","author":"Stiebel-Kalish","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0170","article-title":"Atypical myelin oligodendrocyte glycoprotein antibody disease presenting with isolated elevated intracranial pressure","volume":"1","author":"Valdrighi","year":"2021","journal-title":"Neuroimmunol. Rep."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0175","first-page":"616","article-title":"The diagnosis and treatment of optic neuritis","volume":"112","author":"Wilhelm","year":"2015","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.jneuroim.2023.578083_bb0180","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/1752-1947-8-392","article-title":"Long-term progressive deterioration of visual function after papilledema improved by embolization of a dural arteriovenous fistula in the sigmoid sinus: a case report","volume":"8","author":"Zako","year":"2014","journal-title":"J. Med. Case Rep."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823000693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823000693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:42:30Z","timestamp":1759048950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823000693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":36,"alternative-id":["S0165572823000693"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578083","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paediatric MOG-antibody disease presenting with intracranial hypertension and unilateral vision loss without radiological evidence of optic neuritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578083"}}